Skip to main content
Clinical Trials/DRKS00033153
DRKS00033153
Recruiting
Not Applicable

Investigation of the impact of patient satisfaction with subcutaneous injection of Bulevirtide on therapy response in Hepatitis B/D co-infection - PROs during therapy with bulevirtide

niversitätsklinikum Leipzig0 sites114 target enrollmentDecember 11, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
B17.0
Sponsor
niversitätsklinikum Leipzig
Enrollment
114
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 11, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Leipzig

Eligibility Criteria

Inclusion Criteria

  • age \= 18 years
  • \- written informed consent
  • \- HBV/HDV coinfection
  • \- therapy with bulevirtide
  • \- at least three visits during bulevirtide therapy

Exclusion Criteria

  • \- age \< 18 years
  • \- missing written informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials